
Scientists in the United Kingdom say they have found a major breakthrough in the fight against the coronavirus pandemic.
Moving beyond remdesivir and hydroxychloroquine, UK has moved on to using dexamethasone, an anti-inflammatory steroid.
The University of Oxford released a study today which said that dexamethasone has saved the life of patients critically afflicted by coronavirus.
Being hailed as the next life-saving drug, it has cut deaths among the seriously affected patients surviving on ventilators.
By a fifth!
For those on oxygen supply, the death rate was cut by a fifth. This drug has proven to cut the number of coronavirus deaths. Half of the patients who usually need a ventilator after contracting coronavirus, do not survive.
Additionally, dexamethasone is cheap, priced at 5 Euros in the UK, and it globally available.
The steroid prevents the release of substances in the body that cause inflammation, a nasty symptom of coronavirus infection that makes breathing difficult.
According to the reports, Daily doses of dexamethasone could prevent one in eight ventilated patient deaths and save one out of every 25 patients requiring oxygen alone, the team said.
It was first discovered in 1957 and is commonly prescribed to patients with allergic disorders, skin conditions, ulcerative colitis, arthritis and some types of cancer.
“This is a result that shows that if patients who have COVID-19 and are on ventilators or are on oxygen are given dexamethasone, it will save lives, and it will do so at a remarkably low cost,” said Martin Landray, an Oxford University professor who is co-leading the trial.